Paediatric adverse event rating scale: a measure of safety or efficacy? Novel analysis from the MADDY study

References

• Thomas R, Sanders S, Doust J, et al. Prevalence of attention-deficit/hyperactivity disorder: a systematic review and meta-analysis. Pediatrics. 2015;135(4):e994–1001.
   PubMed Web of Science ®Google Scholar
• Pliszka S. Practice parameter for the assessment and treatment of children and adolescents with attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry. 2007;46(7):894–921.
   PubMed Web of Science ®Google Scholar
• Baweja R, Hale DE, Waxmonsky JG. Impact of CNS stimulants for Attention-Deficit/hyperactivity disorder on growth: epidemiology and approaches to management in children and adolescents. CNS Drugs. 2021;35(8):839–859.
   PubMed Web of Science ®Google Scholar
• Catalá-López F, Hutton B, Núñez-Beltrán A, et al. The pharmacological and non-pharmacological treatment of attention deficit hyperactivity disorder in children and adolescents: a systematic review with network Meta-analyses of randomised trials. PLoS One. 2017;12(7):e0180355.
   PubMed Web of Science ®Google Scholar
• Johnstone JM, Leung B, Gracious B, et al. Rationale and design of an international randomized placebo-controlled trial of a 36-ingredient micronutrient supplement for children with ADHD and irritable mood: the micronutrients for ADHD in youth (MADDY) study. Contemp Clin Trials Commun. 2019;16:100478.
   PubMed Web of Science ®Google Scholar
• Johnstone JM, Hatsu I, Tost G, et al. Micronutrients for attention-deficit/hyperactivity disorder in youth: a Placebo-controlled randomized clinical trial. J Am Acad Child Adolesc Psychiatry. 2021;61(5):647–661.
   PubMed Web of Science ®Google Scholar
• Leheny S. 'Adverse Event,' Not the Same as 'Side Effect' 2017; [cited 2021 Nov 19]. Available from: https://www.pharmacytimes.com/view/adverse-event-not-the-same-as-side-effect.
   Google Scholar
• Findling RL, Robb AS, DelBello MP, et al. A 6-month open-label extension study of vortioxetine in pediatric patients with depressive or anxiety disorders. J Child Adolesc Psychopharmacol. 2018;28(1):47–54.
   PubMed Web of Science ®Google Scholar
• Wehmeier PM, Schacht A, Lehmann M, et al. Emotional well-being in children and adolescents treated with atomoxetine for attention-deficit/hyperactivity disorder: findings from a patient, parent and physician perspective using items from the pediatric adverse event rating scale (PAERS). Child Adolesc Psychiatry Ment Health. 2008;2(1):11.
   PubMedGoogle Scholar
• Lee CS, Williamson LR, Martin SE, et al. Adverse events in very young children prescribed psychotropic medications: preliminary findings from an acute clinical sample. J Child Adolesc Psychopharmacol. 2015;25(6):509–513.
   PubMed Web of Science ®Google Scholar
• American Psychiatric Association. Diagnostic and statistical manual of mental disorders DSM-5. Arlington, VA: American Psychiatric Publishing; 2013.
   Google Scholar
• Jolliffe IT, Cadima JC. Principal component analysis: a review and recent developments. Philos Trans A Math Phys Eng Sci. 2016;374(2065):20150202. A.
   PubMed Web of Science ®Google Scholar
• Bodnar LM, Wisner KL, Luther JF, et al. An exploratory factor analysis of nutritional biomarkers associated with major depression in pregnancy. Public Health Nutr. 2012;15(6):1078–1086.
   PubMed Web of Science ®Google Scholar
• StataCorp. Stata statistical software: Release 15. College Station, TX: StataCorp LLC; 2017.
   Google Scholar
• Pappadopulos E, Jensen PS, Chait AR, et al. Medication adherence in the MTA: saliva methylphenidate samples versus parent report and mediating effect of concomitant behavioral treatment. J Am Acad Child Adolesc Psychiatry. 2009;48(5):501–510.
   PubMed Web of Science ®Google Scholar
• Waschbusch DA, Pelham WE, Jr., Waxmonsky J, et al. Are there placebo effects in the medication treatment of children with attention-deficit hyperactivity disorder? J Dev Behav Pediatr. 2009;30(2):158–168.
   PubMed Web of Science ®Google Scholar
• Cohen A, Plonsky-Toder M, Tirosh E. The short-term placebo response in children with Attention-Deficit hyperactivity disorder (ADHD). J Child Neurol. 2018;33(5):340–346.
   PubMed Web of Science ®Google Scholar
• Gadow K, Sprafkin J. Child and adolescent symptom inventory-5. Checkmate Plus; 2015.
   Google Scholar
• Matza LS, Margolis MK, Deal LS, et al. Challenges of developing an observable parent-reported measure: a qualitative study of functional impact of ADHD in children. Value Health. 2017;20(6):828–833.
   PubMed Web of Science ®Google Scholar
• Storebø OJ, Pedersen N, Ramstad E, et al. Methylphenidate for attention deficit hyperactivity disorder (ADHD) in children and adolescents – assessment of adverse events in non-randomised studies. Cochrane Database Syst Rev. 2018;5(5):Cd012069.
   PubMed Web of Science ®Google Scholar
• Hennissen L, Bakker MJ, Banaschewski T. et al. Cardiovascular effects of stimulant and Non-Stimulant medication for children and adolescents with ADHD: a systematic review and meta-analysis of trials of methylphenidate, amphetamines and atomoxetine. CNS Drugs. 2017;31(3):199–215.
   PubMed Web of Science ®Google Scholar
• Rucklidge JJ, Eggleston MJF, Johnstone JM, et al. Vitamin-mineral treatment improves aggression and emotional regulation in children with ADHD: a fully blinded, randomized, placebo-controlled trial. J Child Psychol Psychiatry. 2018;59(3):232–246.
   PubMed Web of Science ®Google Scholar
• Rucklidge JJ, Harrison R, Johnstone J. Can micronutrients improve neurocognitive functioning in adults with ADHD and severe mood dysregulation? A pilot study. J Altern Complement Med. 2011;17(12):1125–1131.
   PubMed Web of Science ®Google Scholar
• Gordon HA, Rucklidge JJ, Blampied NM, et al. Clinically significant symptom reduction in children with attention-deficit/hyperactivity disorder treated with micronutrients: an open-label reversal design study. J Child Adolesc Psychopharmacol. 2015;25(10):783–798.
   PubMed Web of Science ®Google Scholar
• Rucklidge JJ, Frampton CM, Gorman B, et al. Vitamin-mineral treatment of ADHD in adults. J Atten Disord. 2017;21(6):522–532.
   PubMed Web of Science ®Google Scholar